Page last updated: 2024-08-23

pravastatin and Bone Loss, Perimenopausal

pravastatin has been researched along with Bone Loss, Perimenopausal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobellis, L; De Leo, V; la Marca, A; Lanzetta, D; Morgante, G; Petraglia, F1
Böhm, M; Laufs, U; Nickenig, G; Werner, N1
Galloway, P; Greer, IA; Sattar, N1

Reviews

1 review(s) available for pravastatin and Bone Loss, Perimenopausal

ArticleYear
Statins as novel therapies for osteoporosis?
    European journal of obstetrics, gynecology, and reproductive biology, 2002, Feb-10, Volume: 101, Issue:1

    Topics: Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Osteoporosis, Postmenopausal; Pravastatin

2002

Other Studies

3 other study(ies) available for pravastatin and Bone Loss, Perimenopausal

ArticleYear
Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2003, Volume: 17, Issue:4

    Topics: Absorptiometry, Photon; Bone Density; Bone Remodeling; Estrogen Replacement Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Osteoporosis, Postmenopausal; Pravastatin; Retrospective Studies; Simvastatin

2003
Will statins unseat estrogen?
    Harvard heart letter : from Harvard Medical School, 2000, Volume: 11, Issue:3

    Topics: Anticholesteremic Agents; Estrogens; Female; Heart Diseases; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoporosis, Postmenopausal; Pravastatin

2000
[Statins as new therapeutic possibility in osteoporosis?].
    Deutsche medizinische Wochenschrift (1946), 2001, May-11, Volume: 126, Issue:19

    Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Osteoporosis, Postmenopausal; Pravastatin; Treatment Outcome

2001